Indo Tambangraya Megah Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Indo Tambangraya Megah Tbk trades at Rp23,825 (market cap 27.15T, 1.23M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Indo Tambangraya Megah Tbk is far larger — about 162.2× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Indo Tambangraya Megah Tbk is more actively traded (1.23M versus 96.7K). Which is the better fit depends on your goals.
| ITMG | OBAT | |
|---|---|---|
Market Cap | 27.15T | 167.37B |
Volume | 1.23M | 96.7K |
Lot | 12.28K | 967 |
Turnover | 29.44B | 23.82M |
Average Price | 23,968.15 | 246.34 |
Value | 29.44B | 23.82M |
Indicative Equilibrium Price | 23,825 | 248 |
Indicative Equilibrium Volume | 322 | 41 |
Trailing returns across standard periods
Latest headlines on both assets
PT Indo Tambangraya Megah (the company) was established under its original name of PT Indotambangraya Megah base on notarial deed No.13 of Mr Benny Kristianto, SH, dated on Sep 2, 1987. The Company’s articles of association has been amended several times, most recently by notarial deed No. 33 dated 27 Jul 07 and No. 14 dated 22 Oct 07 of Fathiah Helmi concerning among others, the change in the Capital Structure, par value and public offering.
Read more on ITMG →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →